Proton Pump Inhibitors Decrease Diversity in Gut Microbiome, Increase Risk for Complications

Before reaching for that daily antacid, you might consider what it’s doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures. Study coauthor, Dr. Nicholas Chia comments.

Products You May Like

Articles You May Like

Study shows potential benefits of green tea extracts in Down syndrome
WHO says pandemic has caused more ‘mass trauma’ than WWII
People with vision impairment have higher risk of all-cause mortality
Marlboro maker Altria asks FDA to spread the word that nicotine doesn’t cause cancer
Researchers develop first wearable device to precisely monitor jaundice in newborns

Leave a Reply

Your email address will not be published. Required fields are marked *